Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126746932 | 12674693 | 2 | F | 201602 | 20160831 | 20160823 | 20160902 | EXP | GXKR2016DE003905 | SANDOZ | 0.00 | Y | 0.00000 | 20160902 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126746932 | 12674693 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 250 MG/DAY | 6000 | MG | U | 76593 | 250 | MG | QD | ||||
| 126746932 | 12674693 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 250 MG/DAY | 6000 | MG | U | 76593 | 250 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126746932 | 12674693 | 1 | Cystitis noninfective |
| 126746932 | 12674693 | 2 | Middle ear inflammation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126746932 | 12674693 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126746932 | 12674693 | Alopecia | |
| 126746932 | 12674693 | Anxiety | |
| 126746932 | 12674693 | Asthenia | |
| 126746932 | 12674693 | Cataract | |
| 126746932 | 12674693 | Dizziness | |
| 126746932 | 12674693 | Dry mouth | |
| 126746932 | 12674693 | Dry skin | |
| 126746932 | 12674693 | Food intolerance | |
| 126746932 | 12674693 | Heart rate abnormal | |
| 126746932 | 12674693 | Hormone level abnormal | |
| 126746932 | 12674693 | Impaired healing | |
| 126746932 | 12674693 | Insomnia | |
| 126746932 | 12674693 | Malaise | |
| 126746932 | 12674693 | Memory impairment | |
| 126746932 | 12674693 | Mental impairment | |
| 126746932 | 12674693 | Muscle spasms | |
| 126746932 | 12674693 | Myalgia | |
| 126746932 | 12674693 | Nausea | |
| 126746932 | 12674693 | Nervous system disorder | |
| 126746932 | 12674693 | Neuralgia | |
| 126746932 | 12674693 | Nightmare | |
| 126746932 | 12674693 | Panic attack | |
| 126746932 | 12674693 | Paraesthesia | |
| 126746932 | 12674693 | Polyneuropathy | |
| 126746932 | 12674693 | Rash | |
| 126746932 | 12674693 | Tendon pain | |
| 126746932 | 12674693 | Toxicity to various agents | |
| 126746932 | 12674693 | Varicose vein | |
| 126746932 | 12674693 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126746932 | 12674693 | 1 | 20160116 | 20160120 | 0 | |
| 126746932 | 12674693 | 2 | 20160214 | 20160224 | 0 |